World's Best Scientists 2026 revealed!
Mika J. Mäkelä

Mika J. Mäkelä

D-Index & Metrics

Immunology

D-Index
73
Citations
28811
World Ranking
2087
National Ranking
16

Mika J. Mäkelä publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mika J. Mäkelä sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 355 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mika J. Mäkelä D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mika J. Mäkelä sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mika J. Mäkelä is affiliated with the University of Helsinki in Finland. Their research primarily focuses on Medicine, with a strong emphasis on Immunology and Allergy, Pulmonary and Respiratory Medicine, Physiology, Dermatology, and Surgery. Their body of work includes 256 publications in Medicine, distributed across these subfields: Immunology and Allergy (73 publications), Pulmonary and Respiratory Medicine (63), Physiology (56), Dermatology (19), and Surgery (11).

The main topics Mika J. Mäkelä has worked on cover areas such as Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Respiratory and Cough-Related Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Dermatology and Skin Diseases, and Inhalation and Respiratory Drug Delivery. The respective counts of publications are: Asthma and respiratory diseases (112), Allergic Rhinitis and Sensitization (86), Food Allergy and Anaphylaxis Research (60), Respiratory and Cough-Related Research (48), Chronic Obstructive Pulmonary Disease (COPD) Research (30), Dermatology and Skin Diseases (20), and Inhalation and Respiratory Drug Delivery (18).

The scientist has contributed to several publication venues, which include Allergy (21 publications), Clinical and Translational Allergy (9), Pediatric Allergy and Immunology (6), Clinical & Experimental Allergy (5), and The Journal of Allergy and Clinical Immunology In Practice (4).

Frequent collaborators of Mika J. Mäkelä include Anna S. Pelkonen (29 collaborations), Nikolaos G. Papadopoulos (22), Tari Haahtela (21), Ioana Agache (19), and L. Pekka Malmberg (16).

Notable recent papers authored or co-authored by Mika J. Mäkelä include:

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma, 2020, Allergy
  • Food allergy across the globe, 2021, Journal of Allergy and Clinical Immunology
  • EAACI Biologicals Guidelines-Recommendations for severe asthma, 2020, Allergy
  • <scp>EAACI</scp>Molecular Allergology User's Guide 2.0, 2023, Pediatric Allergy and Immunology
  • Managing food allergy: GA2LEN guideline 2022, 2022, World Allergy Organization Journal

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Environmental biodiversity, human microbiota, and allergy are interrelated

    Ilkka Hanski;Leena von Hertzen;Nanna Fyhrquist;Kaisa Koskinen

  • Viruses and Bacteria in the Etiology of the Common Cold

    Mika J. Mäkelä;Tuomo Puhakka;Olli Ruuskanen;Maija Leinonen

  • EAACI Molecular Allergology User's Guide.

    P.M Matricardi;J Kleine-Tebbe;H.J Hoffmann;R Valenta

  • International consensus on (ICON) pediatric asthma

    N. G. Papadopoulos;H. Arakawa;A. Custovic;J. Gern

  • EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

    G B Pajno;M Fernandez-Rivas;S Arasi;S Arasi;G Roberts;G Roberts;G Roberts

  • Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD

    Mika J. Mäkelä;Vibeke Backer;Morten Hedegaard;Kjell Larsson

  • Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction.

    Sejal Saglani;Kristiina Malmström;Anna S. Pelkonen;L. Pekka Malmberg

  • Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

    Jens U. Rüggeberg;Michael S. Gold;José-Maria Bayas;Michael D. Blum

  • Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.

    U Nurmatov;S Dhami;S Arasi;S Arasi;G B Pajno

  • Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status.

    Kristiina M. Saarinen;Anna S. Pelkonen;Mika J. Mäkelä;Erkki Savilahti

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza A and B Virus Infections

    A. S. Monto;D. M. Fleming;D. Henry;R. de Groot

  • Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review.

    N G Papadopoulos;I Christodoulou;G Rohde;I Agache

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • EAACI Molecular Allergology User's Guide 2.0

    Unknown

  • IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization

    M. J. Mäkelä;A. Kanehiro;L. Borish;A. Dakhama

  • EAACI Biologicals Guidelines—Recommendations for severe asthma

    Ioana Agache;Cezmi Akdis;Mubeccel Akdis;Giorgio Walter Canonica

  • Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.

    M.J. Mäkelä;K. Pauksens;T. Rostila;D.M. Fleming

  • Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

    Josep M Antó;Jean Bousquet;Jean Bousquet;Mübeccel Akdis;Charles Auffray

  • MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine

    J. Bousquet;J. Anto;C. Auffray;M. Akdis

  • Lung function, airway remodelling and inflammation in symptomatic infants: outcome at 3 years

    Kristiina Malmström;Anna S Pelkonen;L Pekka Malmberg;Seppo Sarna

Frequent Co-Authors

Tari Haahtela
Tari Haahtela University of Helsinki
Tiina Laatikainen
Tiina Laatikainen Finnish Institute for Health and Welfare
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Harri Alenius
Harri Alenius Karolinska Institute
Cezmi A. Akdis
Cezmi A. Akdis University of Zurich
Erkka Valovirta
Erkka Valovirta University of Turku
Olli Ruuskanen
Olli Ruuskanen Turku University Hospital
Jean Bousquet
Jean Bousquet University of Montpellier
Claus Bachert
Claus Bachert Karolinska Institute
Graham Roberts
Graham Roberts University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing immunology in the USA opens doors to various interdisciplinary career opportunities, especially in healthcare. Many students interested in combining immunology with patient care consider advancing their education through nursing pathways, such as registered nurse programs or nurse practitioner roles.

For those looking into affordable options, exploring the cheapest psych np programs can provide a cost-efficient route without compromising quality. Salary transparency is crucial when selecting a specialized career path, and resources like dnp salary transparency offer valuable insights into earnings across states for Doctor of Nursing Practice graduates.

Transitioning within nursing specialties, such as moving from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP), is also a viable path. Guidance on this progression can be found through detailed resources explaining the fnp to acnp transition process.

Additionally, accelerated online programs help students fast-track their careers. Exploring some of the accelerated np programs online can be especially beneficial for those aiming to enter the workforce quickly without sacrificing educational quality.

Best Scientists Citing Mika J. Mäkelä

Trending Scientists

Recently Published Articles